UAMA

UAMA (Universal Advanced Medical Analytics) is a biotechnology and healthcare technology company focused on the development of advanced diagnostic and therapeutic solutions for metabolic and rare diseases. The company leverages a proprietary analytics platform to identify novel biomarkers and therapeutic targets, aiming to streamline the drug discovery process and improve patient outcomes. UAMA's current pipeline includes several pre-clinical programs targeting specific metabolic pathways. By integrating data-driven insights with traditional biotech research, UAMA seeks to address significant unmet needs in the healthcare sector. The company is positioned at the intersection of life sciences and advanced data analytics.